






The thesis entitled “Towards The Total Synthesis of Phorboxazole A, Synthesis And Biological Evaluation of Coumarin Analogues As DNA Gyrase Inhibitors And Development of New Synthetic Methodologies” is divided into three chapters.
CHAPTER I: This chapter further divided into two sections.
SECTION A: This section describes biological importance of some antitumor    molecules     	and earlier synthetic approaches to C20-C32 fragment of the    	phorboxazoles.
SECTION B: This section comprises present work, the stereoconvergent synthesis of C20-C32 fragment of phorboxazoles.
Phorboxazole A and B (Scheme 1) rare marine macrolides isolated from the Indian ocean sponge Phorbas sp. by Searle and Molinski.1 Both C13 epimers comprised of a 21-membered macrolide ring that embodies three oxane rings, one oxazole and subtends a side chain that contains a second oxazole and a hemiketal oxane ring. These are among the most cytostatic natural products known, inhibiting the growth of tumor cells at nanomolar concentrations with mean GI50 = 1.58 x 10-9 M against NCI panel 60 tumor cell lines. These scarce natural products arrest cancer cell growth in S phase at low to subnanomolar concentrations, making them promising candidates for therapeutic development. The enormous biological activity and the fascinating molecule structure have stimulated synthetic efforts by a number of research groups and seven elegant total syntheses have been reported so far. The remarkable biological activities associated with the phorboxazoles make these compounds important leads for biotherapeutic development.2










	The bycyclic alcohol 6 was prepared from the bycyclic ketone 4 in three step sequence using (-) Ipc2BH asymmetric hydroboration3 as a key step. It was converted to keto compound 7 by PCC oxidation in DCM in 85% yield (Scheme 2). Next task was to open the bicyclic ketone 7. It was thought that the best way of opening the bicyclic ketone was by making the corresponding ester 8 and hydrolyzing it. Thus a Baeyer – Villiger oxidation of the ketone 7 using m-CPBA and NaHCO3 in DCM yielded the ester 8 in 90% yield (Scheme 2). 

Scheme 2
Methanolysis of lactone 8 using catalytic amount of sulfuric acid in MeOH afforded the acetal ester 9 in 85% yield with a minor amount of the -isomer (at C-1 center). This ester consists of three stereocenters out of five in the central pyran moiety 1.  Next we turned our attention to obtain the stereocenters at C1 and C2 carbons of the pentasubstituted pyran ring 1. In that direction ester functionality of 9 was reduced with LAH in THF at ambient temparature to the corresponding alcohol 10 in 90% yield.  Then benzylation of the resulting primary alcohol with BnBr, NaH, and TBAI (catalytic) in THF furnished dibenzyl acetal 11 in 95% yield (Scheme 3).

Scheme 3






	Having made flat form to obtain the stereocenters at C1 and C2 of pentasubstituted pyran moiety 1, we thought to epimerize the α-methyl at C2 of the lactone 13. For this purpose we made experiments using MeONa/MeOH and refluxing KOH/EtOH which were resulted in ring opening of the lactone to corresponding hydroxy ester and hydroxy acid respectively. And acid catalyzed cyclization of hydroxy acid resulted  in epimerized lactone 14, and base catalyzed cyclization of hydroxy ester also led to the same 14. To avoid ring opening of lactone it was thought that to use mild base such as DBU. Epimerization was successfully carried out with DBU in THF for 12 h with 85% yield with 100% conversion (Scheme 5).4 Epimerization was confirmed by 1H NMR and NOE studies.

Scheme 5
	Accordingly, nucleophilic addition of lithiumtrimethylsilyl acetylide which was generated in situ from acetylenetrimethylsilane and n-BuLi at -78 oC to the resulting epi-lactone 14 at -78 oC in THF provided inseparable anomeric mixture of hemiketals 15 in 90% yield. Reduction of hemiketal to pyran 16 was carried out with excess Et3SiH/BF3.Et2O in CH2Cl2/CH3CN (1:1) at -40 oC.5 The reaction was proceeded to completion within 1 h, furnishing exclusively pentasubstituted pyarn moiety 16 in which ether linkage between C1 and C5 is in syn configuration (Scheme 6). The stereochemistry of 16 was confirmed by 1H NMR and NOE experiments.

Scheme 6
	Desilylation and hydrolysis of the triple bond via oxymercuration in Markownikoff’s fashion was effected in a single transformation using yellow HgO and aq.H2SO4 in refluxing acetone for 2 h with 70% yield to give keto oxane 2 (Scheme 6).6

Scheme 7
	Many attempts went in vain to make the desired oxazole 5. Finally we followed the Conforth’s synthesis of oxazoline 19, which was prepared by employing ethyl acetimidate hydrochloride 17 and DL-serine methyl ester hydrochloride 18 in CH2Cl2 in presence of Et3N for 12 h. The resulting oxazoline 19 was oxidized to oxazole 5 by using CuBr2, HMTA and DBU in CH2Cl2 for 2 h at ambient temparature in 75% yield. Further the ester functionality in oxazole was reduced to alcohol 20 by employing DIBAL-H.7 Then the alcohol was made into thioether 21 under Mitsnobu reaction conditions using mercaptobenzothiazole, DEAD and TPP in THF for 4 h. Thioether was oxidized to oxazole sulfone 3 by oxone in THF:H2O:MeOH (2:1:1) for 12 h in 90 % yield (Scheme 7).
Scheme 8
Coupling of oxazole sulfone and the ketone under the modified Julia olefination reaction conditions gave the C20-C32 fragment as separable E:Z isomers in a ratio of 9:1 in 50% yield (40% conversion) based on recovered starting material (Scheme 8).
	In conclusion, the practical synthesis of the penta substituted pyran C20-C32 fragment achieved from bycyclic ketone is described. Modified Julia olefination reaction between sulfone and the ketone was also achieved. 

CHAPTER II : This chapter again divided into two sections.
SECTION A: This section deals with introduction to coumarin and quinolone antibiotics and dual action drugs.
SECTION B: This section deals with the present work, synthesis and biological                                              		    evaluation of coumarin linked fluoroquinolones, phthalimides and naph-		                thalimides as potential DNA gyrase Inhibitors. 
	Over the past decade, bacterial DNA gyrase has drawn much attention as a selected target for finding potent antibacterial agents. Accordingly, a number of synthetic quinoline antibacterial agents have been developed and are now widely used for treatment of bacterial infectious diseases. Quinolones inhibit DNA gyrase and topoisomerase  IV, and  cause  bacterial cell death. Besides the quinolones, naturally occurring antibacterial agents, such as novobiocin  (NB; Fig. 1) have also been identified as bacterial DNA gyrase inhibitors.8  Novobiocin  inhibits ATPase activity of DNA gyrase by competing  with ATP for binding to the gyrase subunit B. Based on this background it was considered of interest to prepare new type of dual-acting coumarin-linked hybrids possessing phthalimide, naphthalimide and quinolone moieties to unravel their antibacterial activity and DNA gyrase inhibition potential.




	The coumarin precursors 4-(1-piperazinyl)-2H-1-benzopyran-2-one 25a and 25b were synthesized9 from the starting materials o-hydroxy acetophenones 23a, 23b in two step sequence. Compounds 23a, 23b were treated with diethylcarbonate in the presence of Na to reflux for 4 h to obtain  substituted 4-hydroxy coumarins 24a, 24b which 
inturn heated with piperazine at 160 oC for 1h to obtain the precursors 25a and 25b (Scheme11). 
Scheme 9

	 Quinolone precursors were obtained from substited anilines 26a and 26b by reacting with diethylethoxymethylenemalonate at 110 oC for 1.5 h to give 2-(3,4-dihaloanilino-methylene)melonates 27a, 27b which upon heating with diphenylether at 250 oC for 1h furnished  28a, 28b (Scheme 10).

Scheme 10















	The in-vitro antibacterial activity of the compounds was assessed along with ciprofloxacin by Kirby-Bauer method on both Gram negative and Gram-positive bacteria. The minimum inhibitory concentration of the compounds was determined by inoculating the test organisms (E. coli MTCC 443, B. subtilis MTCC 736) on Mueller-Hinton agar plates with different concentrations of compound (4 mg/mL, DMSO) followed by incubation at 37 oC for 16-18 hrs. To ensure that the solvent had no effect on bacterial growth, a control test with DMSO was also performed. Some of the compounds exhibited mild activity against E. coli. (Table1). However, these compounds were almost inactive against B. subtilis (MIC >60 g/mL). 

Inhibition of DNA supercoiling














Table 1. Minimal inhibitory concentrations (MIC) of coumarin hybrids against DNA gyrase and bacteria













 12	36a	CH3	-	-	2	  35	30
 13	36b	CH3	-	-	3	>60	30
 14	36c	C2H5	-	-	2	  42	30
 15	36d	C2H5	-	-	3	>60	30




 	Ciprofloxacin					            5	10

aNo inhibition was observed.

Conclusion




CHAPTER III: This chapter describes new methodologies for the synthesis of 2-				    deoxyglycosides and 2,3-unsaturated glycosides. This chapter again 			    divided into two sections.
SECTION A: This section describes the synthesis of 2-deoxyglycosides from D-glycals using CeCl3.7H2O-NaI as a novel reagent.














SECTION B: This section describes the synthesis of 2,3-unsaturated C and O and S-       			glycosides from D-glycals using phosphomolybdic acid supported on 			silica gel as an efficient catalyst.

	The acid-catalyzed allylic rearrangement of glycals in the presence of nucleophiles such as alcohols, thiols etc., and known as Ferrier rearrangement11 is widely employed to obtain 2, 3-unsaturated glycosides. Allyl C-glycosides are attractive synthons due to the presence of terminal double bond that is amenable to easy functionalization, for instance, by hydroxylation, hydrogenation, epoxidation and amino hydroxylation.  These glycosides or pseudoglycals represent versatile chiral intermediates towards the synthesis of modified carbohydrates and nucleosides with important pharmacological properties. This class of compounds can be transformed in to 2-deoxy or 2, 3-dideoxy sugars, which are building blocks for the total synthesis of many antibiotics.12 Due to its great significance in the area of carbohydrate chemistry, there has been a growing interest in the improvement of the Ferrier reaction by using a variety of catalysts.  
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